View in EDS

The Limitless Future of RNA Therapeutics.

Saved in:
Bibliographic Details
Title: The Limitless Future of RNA Therapeutics.
Authors: Damase TR; RNA Therapeutics Program, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Sukhovershin R; RNA Therapeutics Program, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Boada C; Colleges of Medicine, Engineering, Texas A&M University and Houston Methodist Hospital, Houston, TX, United States., Taraballi F; Center for Musculoskeletal Regeneration, Houston Methodist Research Institute, Houston, TX, United States.; Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, United States., Pettigrew RI; Colleges of Medicine, Engineering, Texas A&M University and Houston Methodist Hospital, Houston, TX, United States., Cooke JP; RNA Therapeutics Program, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States.
Source: Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2021 Mar 18; Vol. 9, pp. 628137. Date of Electronic Publication: 2021 Mar 18 (Print Publication: 2021).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101632513 Publication Model: eCollection Cited Medium: Print ISSN: 2296-4185 (Print) Linking ISSN: 22964185 NLM ISO Abbreviation: Front Bioeng Biotechnol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33816449
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Limitless Future of RNA Therapeutics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Damase+TR%22">Damase TR</searchLink>; RNA Therapeutics Program, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Sukhovershin+R%22">Sukhovershin R</searchLink>; RNA Therapeutics Program, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Boada+C%22">Boada C</searchLink>; Colleges of Medicine, Engineering, Texas A&M University and Houston Methodist Hospital, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Taraballi+F%22">Taraballi F</searchLink>; Center for Musculoskeletal Regeneration, Houston Methodist Research Institute, Houston, TX, United States.; Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Pettigrew+RI%22">Pettigrew RI</searchLink>; Colleges of Medicine, Engineering, Texas A&M University and Houston Methodist Hospital, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Cooke+JP%22">Cooke JP</searchLink>; RNA Therapeutics Program, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101632513%22">Frontiers in bioengineering and biotechnology</searchLink> [Front Bioeng Biotechnol] 2021 Mar 18; Vol. 9, pp. 628137. <i>Date of Electronic Publication: </i>2021 Mar 18 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101632513 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-4185 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222964185%22">22964185 </searchLink><i>NLM ISO Abbreviation: </i>Front Bioeng Biotechnol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33816449
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fbioe.2021.628137
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 628137
    Titles:
      – TitleFull: The Limitless Future of RNA Therapeutics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Damase TR
      – PersonEntity:
          Name:
            NameFull: Sukhovershin R
      – PersonEntity:
          Name:
            NameFull: Boada C
      – PersonEntity:
          Name:
            NameFull: Taraballi F
      – PersonEntity:
          Name:
            NameFull: Pettigrew RI
      – PersonEntity:
          Name:
            NameFull: Cooke JP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 03
              Text: 2021 Mar 18
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2296-4185
          Numbering:
            – Type: volume
              Value: 9
          Titles:
            – TitleFull: Frontiers in bioengineering and biotechnology
              Type: main
ResultId 1